See our Talk at HiMSS 2019 – Integrating Clinico-Genomic Data for Precision Health

We’ve landed in Orlando and are ready to enjoy our time at the annual HiMSS Global Conference! In addition to 45,000 other healthcare professionals attending, we are taking the full opportunity of the sun to discuss and discover new ways to utilize information and technology to accelerate healthcare insights. Learn more about the HiMSS Conference.

Join us at the Amazon Web Services Booth #5058 where we will be presenting how population-scale data collection initiatives are pioneering new frontiers in precision medicine, while simultaneously bringing about new challenges on integration of diverse datasets and extraction of high-impact insights. Researchers must overcome the complexities of datasets including multi-omic and clinical data securely and at scale.

We will discuss the recently launched DNAnexus Apollo™, a scalable cloud platform, with flexible data models and intuitive analysis & visualization tools that eliminates the complexities many researchers face, enabling integration of big data, driving to actionable insights and rapid discovery. Additional topics covered:

  • Success in powering precision medicine
  • Trends shaping the future of healthcare
  • Showcase multi-omic & clinical data science exploration, analysis, & discovery
  • How cloud-based data analysis and secure collaboration drive scientific discovery
Integrating clinico-genomic data for precision health

Aniket Deshpande, Science Lead

Tuesday, February 12 at 4:30pm

AWS Booth #5058

                   Aniket Deshpande

Leveraging the trusted best-in-class DNAnexus security and privacy framework, including HIPAA, CLIA, GxP, and FedRAMP compliance DNAnexus Apollo™ was designed to seamlessly integrate and analyze diverse datasets, including multi-omic & clinical data, driving actionable insights in real time. DNAnexus Apollo™ is currently powering large-scale geno/pheno projects, including the RGC UK Biobank Consortium Data Delivery — one of the largest population-scale projects containing exome sequencing results and clinical data from 500,000 individuals.

Find us at the talk or schedule a meeting with a member of our team.